Our Team


We have purposefully built our team with exceptional company-builders and passionate scientists. We have hands-on experience and prior knowledge of translating novel biomarker discoveries into groundbreaking diagnostics.


Minnie Sarwal, MD, PhD

Founder, Interim CEO

Renowned nephrologist who heads a federally funded academic lab and leads the precision medicine program in solid organ transplantation and kidney diseases at UCSF.

Joshua Y. Yang, M.Eng.

Founder, Director of Assay Development

Bioengineering, clinical, and entrepreneurial experience across five academic institutions and two startup companies, including co-invention of the KIT Bio assay.

Todd Whitson

Todd Whitson, M.S.

Chief Commercial Advisor

21 years of assay experience in pharmaceutical discovery, life science platform evaluation, and molecular diagnostic development from feasibility through commercialization including NGS applications.

Matthew Meyer WSGR Square.jpg

Matthew J. Meyer, J.D.

Chief Business Advisor

Experienced executive across a wide range of private and public biopharma, med tech and precision medicine companies in the U.S. and Europe, including Pfizer, Novartis, CareDx and Counsyl

Scientific Advisory Board


Ron Shapiro, M.D.

Director, Mt. Sinai Hospital, NY

Kidney Transplant


David Jayne, MD

Cambridge University, UK



Flavio Vincenti, M.D.

University of California, San Francisco

Kidney Transplant


Tom Chi, MD

Director, University of California, San Francisco


Richard Lafayette, MD

Stanford University, National Kidney Foundation



Ramona Doyle, MD

Stanford University, University of California, San Francisco


Martha Pavlakis, MD

Director, Deaconess Beth Israel Medical Center, Harvard Medical School


Tara K. Sigdel, Ph.D.

University of California, San Francisco

Biochemistry, Assay Development


Business Advisory Board


Ajit Singh, PhD

Managing Partner, Artiman Ventures

Strategy and Investment Advisor

David Savoca mugshot - lowres Square.png

David Savoca

Information Technology

Vern Norviel square.jpg

Vern Norviel

Wilson Sonsini Goodrich and Rosati

Patent Portfolio; FTO

Ashok Square.jpg

Ashok Bhagat

Information Technology

Elliot Cowan Square.jpeg

Elliot Cowan

FDA, Partners in Diagnostics, LLC

Regulatory Strategy Advisor

Mike Danaher

Wilson Sonsini Goodrich and Rosati

Patent Portfolio; FTO